Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 USD | -0.35% | -2.68% | -7.06% |
Financials (USD)
Sales 2024 * | 5.43M | Sales 2025 * | 33.37M | Capitalization | 28.77M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -7M | EV / Sales 2024 * | 5.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.86 x |
P/E ratio 2024 * |
-1.06
x | P/E ratio 2025 * |
-4.77
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Daré Bioscience, Inc.
1 day | -3.80% | ||
1 week | +1.17% | ||
Current month | -41.66% | ||
1 month | -40.22% | ||
3 months | -9.52% | ||
6 months | -33.33% | ||
Current year | -7.44% |
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 75 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.2872 | +0.42% | 126 664 |
24-04-24 | 0.286 | -3.80% | 436,098 |
24-04-23 | 0.2973 | +0.68% | 323,196 |
24-04-22 | 0.2953 | +5.46% | 165,190 |
24-04-19 | 0.28 | -5.12% | 555,803 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.44% | 28.77M | |
+4.09% | 43.84B | |
+47.36% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- DARE Stock